我国丙型肝炎的分子流行病学  

Molecular epidemiology of hepatitis C in China

作　　者：李晓鹤 饶慧瑛[1] Li Xiaohe;Rao Huiying(Peking University People’s Hospital,Peking University Hepatology Institute,Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases,Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis,Beijing 100044,China)

机构地区：[1]北京大学人民医院,北京大学肝病研究所,丙型肝炎和肝病免疫治疗北京市重点实验室,非酒精性脂肪性肝病诊断北京市国际科技合作基地,北京100044

出　　处：《国际流行病学传染病学杂志》2023年第4期235-238,共4页International Journal of Epidemiology and Infectious Disease

摘　　要：HCV感染是我国慢性肝病发病的重要原因,其流行率和基因型分布随人群和地理区域不同存在差异。近年来,我国HCV感染分子流行病学发生变化,在血液透析患者、静脉药物注射人群、高危性行为人群中具有较高流行率,需要引起重视。Hepatitis C virus(HCV)infection is an important cause of chronic liver disease in China,and its prevalence and genotype distribution vary among different populations and geographical regions.In recent years,there have been changes in the molecular epidemiology of hepatitis C infection in China.It has a high prevalence rate among people with hemodialysis,injecting drug user,and high-risk sexual behavior,which needs to be taken seriously.

关 键 词：丙型肝炎病毒 分子流行病学 血液透析 静脉药瘾 高危性行为 

分 类 号：R512.63[医药卫生—内科学] R181.3[医药卫生—临床医学]